WHODrug Koda, developed by Uppsala Monitoring Centre (UMC), is an automated coding service, which uses artificial intelligence (AI) to automate the coding of drug names and ATC selections, improving consistency and operational efficiency. It can also be used to accelerate dictionary upgrades, including the transition from WHODrug B2 format to B3.
Through API (Application Programming Interface) web services, the coding engine can be integrated with custom or off-the-shelf drug safety, medical coding, or data management systems.
In this webinar, Perficient and UMC discussed WHODrug Koda and how you can integrate it into your medical coding activities.
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
Definitions, Severity assessment, Seriousness assessment
Naranjo algorithm, Preventability assessment
By
Ms. B. Mary Vishali
Department of Pharmacology
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
Definitions, Severity assessment, Seriousness assessment
Naranjo algorithm, Preventability assessment
By
Ms. B. Mary Vishali
Department of Pharmacology
Electronic Data Capture & Remote Data CaptureCRB Tech
CRB Tech is one of the best leading Software Development Company in Pune. We are offering Software Development Services as well as IT Training including Java, Dot Net, SEO and Clinical Research training in pune.
INSTITUTIONAL REVIEW BOARD (IRB/IEC).pptxRAHUL PAL
The International Council on Harmonisation (ICH) defines an institutional review board (IRB) as a group formally designated to protect the rights, safety and well-being of humans involved in a clinical trial by reviewing all aspects of the trial and approving its startup. IRBs can also be called independent ethics committees (IECs).
An IRB/IEC reviews the appropriateness of the clinical trial protocol as well as the risks and benefits to study participants. It ensures that clinical trial participants are exposed to minimal risk in relation to any benefits that might result from the research.
IRB/IEC members should be collectively qualified to review the scientific, medical and ethical aspects of the trial.
Per the FDA, an IRB/IEC should have:
At least five members.
Members with varying backgrounds.
At least one member who represents a non-scientific area (a lay member).
At least one member who is not affiliated with the institution or the trial site (an independent member).
Competent members who are able to review and evaluate the science, medical aspects and ethics of the proposed trial.
Causality Assessment in PharmacovigilanceClinosolIndia
Causality assessment is the process of determining whether a particular drug or medical intervention is the cause of an adverse event or reaction that has occurred in a patient. The following are some key principles and factors that are considered in causality assessment:
Temporal relationship: The timing of the adverse event in relation to the drug or intervention is a key factor in causality assessment. If the adverse event occurs shortly after the drug is administered or the intervention is performed, this may suggest a causal relationship.
Biological plausibility: The biological mechanisms by which the drug or intervention could cause the adverse event should be considered. If there is a plausible biological mechanism for the adverse event, this may support a causal relationship.
Alternative explanations: Other factors that could have caused the adverse event, such as pre-existing medical conditions, should be considered and ruled out before attributing the event to the drug or intervention.
Dose-response relationship: If there is a clear dose-response relationship between the drug or intervention and the adverse event, this may suggest a causal relationship.
Rechallenge: If the adverse event reoccurs when the drug or intervention is readministered, this may provide further evidence for a causal relationship.
There are several methods for conducting causality assessment, including the Naranjo algorithm, the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) system, and the Liverpool Causality Assessment Tool (LCAT). These methods use different criteria and scoring systems to evaluate the likelihood of a causal relationship between the drug or intervention and the adverse event.
Signal detection is a process used in pharmacovigilance to identify potential safety issues or new safety information associated with a medicinal product. The goal of signal detection is to detect signals, or potential safety concerns, as early as possible in order to allow for timely risk management and safety interventions.
Signal detection typically involves analyzing large amounts of safety data, including adverse event reports, clinical trial data, post-marketing surveillance data, and other sources of safety information. The data is analyzed using statistical methods and algorithms to identify any patterns or trends that may suggest a potential safety concern.
Once a potential safety concern is identified, further investigation is typically required to confirm the signal and assess the magnitude of the risk. This may involve conducting additional studies, analyzing the available data in more detail, or consulting with regulatory agencies and other stakeholders.
Signal detection is an ongoing process that continues throughout the life cycle of a medicinal product. The process is critical for ensuring the ongoing safety and effectiveness of medicinal products, and is an important component of pharmacovigilance activities.
Visit:www.acriindia.com
ACRI is a leading Clinical data management training Institute in Bangalore India.
ACRI creates a value add for every degree. Our PGDCRCDM course is approved by the Mysore University. Graduates and Post Graduates and even PhDs have trained with us and got enviable positions in the Clinical Research Industry. ACRI supplements University training with Industry based training, coupled with hands-on internships and projects based on real case studies. The ACRI brand gives the individual the confidence and expertise to join the ever-growing workforce both in the country and abroad.
Electronic Data Capture & Remote Data CaptureCRB Tech
CRB Tech is one of the best leading Software Development Company in Pune. We are offering Software Development Services as well as IT Training including Java, Dot Net, SEO and Clinical Research training in pune.
INSTITUTIONAL REVIEW BOARD (IRB/IEC).pptxRAHUL PAL
The International Council on Harmonisation (ICH) defines an institutional review board (IRB) as a group formally designated to protect the rights, safety and well-being of humans involved in a clinical trial by reviewing all aspects of the trial and approving its startup. IRBs can also be called independent ethics committees (IECs).
An IRB/IEC reviews the appropriateness of the clinical trial protocol as well as the risks and benefits to study participants. It ensures that clinical trial participants are exposed to minimal risk in relation to any benefits that might result from the research.
IRB/IEC members should be collectively qualified to review the scientific, medical and ethical aspects of the trial.
Per the FDA, an IRB/IEC should have:
At least five members.
Members with varying backgrounds.
At least one member who represents a non-scientific area (a lay member).
At least one member who is not affiliated with the institution or the trial site (an independent member).
Competent members who are able to review and evaluate the science, medical aspects and ethics of the proposed trial.
Causality Assessment in PharmacovigilanceClinosolIndia
Causality assessment is the process of determining whether a particular drug or medical intervention is the cause of an adverse event or reaction that has occurred in a patient. The following are some key principles and factors that are considered in causality assessment:
Temporal relationship: The timing of the adverse event in relation to the drug or intervention is a key factor in causality assessment. If the adverse event occurs shortly after the drug is administered or the intervention is performed, this may suggest a causal relationship.
Biological plausibility: The biological mechanisms by which the drug or intervention could cause the adverse event should be considered. If there is a plausible biological mechanism for the adverse event, this may support a causal relationship.
Alternative explanations: Other factors that could have caused the adverse event, such as pre-existing medical conditions, should be considered and ruled out before attributing the event to the drug or intervention.
Dose-response relationship: If there is a clear dose-response relationship between the drug or intervention and the adverse event, this may suggest a causal relationship.
Rechallenge: If the adverse event reoccurs when the drug or intervention is readministered, this may provide further evidence for a causal relationship.
There are several methods for conducting causality assessment, including the Naranjo algorithm, the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) system, and the Liverpool Causality Assessment Tool (LCAT). These methods use different criteria and scoring systems to evaluate the likelihood of a causal relationship between the drug or intervention and the adverse event.
Signal detection is a process used in pharmacovigilance to identify potential safety issues or new safety information associated with a medicinal product. The goal of signal detection is to detect signals, or potential safety concerns, as early as possible in order to allow for timely risk management and safety interventions.
Signal detection typically involves analyzing large amounts of safety data, including adverse event reports, clinical trial data, post-marketing surveillance data, and other sources of safety information. The data is analyzed using statistical methods and algorithms to identify any patterns or trends that may suggest a potential safety concern.
Once a potential safety concern is identified, further investigation is typically required to confirm the signal and assess the magnitude of the risk. This may involve conducting additional studies, analyzing the available data in more detail, or consulting with regulatory agencies and other stakeholders.
Signal detection is an ongoing process that continues throughout the life cycle of a medicinal product. The process is critical for ensuring the ongoing safety and effectiveness of medicinal products, and is an important component of pharmacovigilance activities.
Visit:www.acriindia.com
ACRI is a leading Clinical data management training Institute in Bangalore India.
ACRI creates a value add for every degree. Our PGDCRCDM course is approved by the Mysore University. Graduates and Post Graduates and even PhDs have trained with us and got enviable positions in the Clinical Research Industry. ACRI supplements University training with Industry based training, coupled with hands-on internships and projects based on real case studies. The ACRI brand gives the individual the confidence and expertise to join the ever-growing workforce both in the country and abroad.
According to Deloitte, approximately 50% of biotech/pharma collaborations will fail, part of what leads to that failure is ambiguity in communication. "Where did this result come from?", "What was the protocol used in this experiment?", "What does this value represent?"
At Aspen Biosciences, our Pipeline platform makes it easy for drug discovery companies, CROs, and pharmas to collaborate and share data seamlessly, using a common, industry-standard vocabulary.
Customer Healthcare app
Connect to your customer
- Have the full customer profile and overview.
- Know the history and see changes in your patients medical situation.
- Find out immediately if your customers receive generic medicals instead of heal care products.
- Relieve your service and support team by artificial intelligence and let the service bot to reply support cases.
IDMP Implementation - Impact on Data, Systems and Processes. How to cover gap...Torben Haagh
ISO IDMP will be mandatory from July 1st 2016 and it will make a fundamental impact on the way the pharmaceutical industry is required to collect, manage and submit relevant data. Now is the last call for all marketing authorisation holders to (re)think their data submission policies and processes to make sure you close your IDMP implementation gaps in the next 12 month and have a clear vision of the next challenges lying ahead!
Don’t miss out on the opportunity to get your questions answered, to benchmark the stage of your preparation, to initiate partnerships and to take an active part in designing the RIM’s community future agenda! Join us this summer in Berlin and gain valuable, practical information:
# Learn how to assess and analyse data requirements for the IDMP standards by discussing possible interpretations with our expert from regulatory bodies on-site!
# Benchmark your own IDPM Implementation process with peers from both big and mid-size pharma
# Share insights how the IDMP standards are changing the interactions between IT-Systems, company departments, contract manufacturers and regulatory agencies
# Discuss and compare with your peers experiences with vendors and solution providers offering help to achieve your IDMP implementation goals!
For more information visit our website: http://bit.ly/EventWebsite
If you would like to be part of the conference, you can register now here: http://bit.ly/Register-Event
optum360.comOptum360 powers HIM and CDI modernizationE.docxvannagoforth
optum360.com
Optum360 powers HIM and CDI modernization
Experience matters
Since 1999, Optum has expanded its
LifeCode NLP technology based on
success driven by the performance of
its clients. The depth of experience
spans across health care settings,
medical specialties and varying
encounters covering both physician-
and hospital-based services.
The only patented NLP
technology on the market today
Decision-makers are facing the need to transition to value-based care with pressure to move toward
metrics around quality, safety and outcomes, in addition to optimizing reimbursement. Reliable and
accurate capture of information in these areas is growing the expectations of traditional HIM operations
to work in concert with colleagues in CDI, case management and compliance. NLP technology that can
accurately capture information at the concept level to refl ect the complete health story of a patient is key to
meeting these expectations today in CAC, and tomorrow across settings.
LifeCode NLP technology is uniquely suited to meet this market need through its patented capabilities
that allow recognition of precise clinical details along with content, syntax and multiple semantic
attributes. It does this through an integration of linguistic analysis with a knowledge base of more
than 10 million medical facts.
Better together: A comprehensive solution
The Optum Enterprise Computer-Assisted Coding (CAC) and Optum CDI 3D platform bring together the
power of LifeCode NLP with the tools needed to streamline operations and the partnership to ensure your
ongoing success. Powerful technology combined with a team of experts armed with comprehensive analytics
ensures your organization is positioned for success in today’s ever-changing health care environment.
Optum Enterprise CAC leverages LifeCode NLP to identify code-able facts.
With Optum Enterprise CAC, coders leverage the encoder, logic, workfl ow and NLP code assignment
functionalities to ensure more complete and accurate coding, while providing the traceability and
operational tools to ensure cases are coded in a timely manner.
Optum CDI 3D leverages LifeCode NLP to identify gaps in documentation.
Optum CDI 3D takes documentation improvement opportunities to the next level, with intuitive, intelligent
and clinically based case-fi nding technology that allows CDI specialists to concentrate effort on the right
cases at the right time. In addition, the Optum CDI Program offers the education, preparation and support
to drive the successful growth in your program.
By the numbers:
• Approximately 500 Enterprise CAC clients
sites now using Enterprise CAC, with 100
more scheduled for implementation
• Nearly 200 sites now using CDI 3D, with
100 more scheduled for implementation
• Successful integration with 30+ hospital
EHR and revenue cycle systems
• 1 billion unique clinical documents
processed by LifeCode annually
• Proprietary NLP approach supported by
fi ve pat ...
SDL How Global Life Sciences Leaders Solve the Customer Experience PuzzleChip Gettinger
Having the right global customer experience strategy that fully integrates global product labeling interactions with real world patient care is critical for beating competitors and earning your customers’ loyalty.’
Welcome to the M Lab™ Collaboration Centers – where customers can use non-GMP lab spaces to operate equipment, evaluate processes and receive real-time technical support without disrupting production.
Plan your visit: www.merckmillipore.com/mlab
More and more health economies across the globe are deploying Electronic Health Records with some countries reaching full adoption by 2017. This means we, as healthcare marketers, now have a vital new channel to reach and educate decision makers.
Enriching Content with Semantic Tagging
K. Krishna (Molecular Connections (India))
Jignesh Bhate (Molecular Connections, India)
In spite of rapid transformation of publishing landscape brought about by digital technologies, content remains the focal point for publishers as well as consumers. Content deluge has increasingly made it challenging for consumers to discover and analyze relevant content. Approaches like semantic tagging provide an effective solution to this burgeoning problem.
Semantic tagging facilitates enhanced knowledge discovery and management, automated categorization of content, improved web navigation, easier integration of new knowledge in existing content and better exchange of information across diverse services.
In this talk, we will discuss about various content enrichment methodologies and share some insights from application of our in-house semantic tagging platform for enriching content of publishers.
Similar to Automate Medical Coding With WHODrug Koda (20)
The world is quite a different place than it was six months ago, and with the 2020 holiday season fast approaching, the pressure is on to meet revenue goals in what’s been an uncertain year.
In August, we surveyed 154 marketing executives to find out what they think is likely to happen this holiday season and how they are preparing for it. The results are fascinating, and we’ve distilled them into clear actions you can take right now to adapt and prepare for a very different 2020 holiday season.
In this webinar, Eric Enge (Principal, Digital Marketing at Perficient) and Jim Hertzfeld (Chief Strategist, Digital at Perficient) discussed:
How marketers have already adapted and where they see the most opportunity moving forward
What will be different this holiday season and how to adjust your strategy accordingly
Ways to identify and meet changing customer expectations, wants, and needs
How to determine if your priorities or investments should change
What actions you can take right now to be successful
Transforming Pharmacovigilance Workflows with AI & Automation Perficient, Inc.
Medical information call centers have an opportunity to transform the way they capture, code, and analyze adverse events (AEs) and product quality complaints (PQCs) with artificial intelligence (AI) and automation.
The use of such innovative technology improves data quality and consistency, compliance, and operational efficiency. It helps reduce the frequency of your pharmacovigilance (PV) operations resources going home, saying, “I have more to do at the end of the day than I did when I started."
Our one-hour, on-demand webinar shows you how you can use AI and automation to turbo-charge your end-to-end PV system. Use cases and demonstrations will include:
Analyzing safety data
Auto-coding verbatim terms to official medical dictionary terms
Auto-creating an AE case in your database
Converting speech to text
The Secret to Acquiring and Retaining Customers in Financial ServicesPerficient, Inc.
Data, when leveraged effectively, can help you segment and target customers, analyze spending habits, and can create a personalized experience that builds value and customer loyalty.
Without a 360-degree view of your customers, you can’t properly target them with real-time personalized offers, advice, and other services. In addition, lack of customer intelligence creates lost opportunities for banks and insurers to cross-sell and upsell new products and services.
Our one-hour webinar covered how customer intelligence platforms can help you engage, acquire, and retain customers.
Oracle Strategic Modeling Live: Defined. Discussed. Demonstrated.Perficient, Inc.
The only thing certain about forecasting in a volatile economy is that the future is unpredictable. Historically, organizations have effectively utilized statistical techniques for short-term business planning, but leveraging actuals no longer allows us to predict the future. The ability to be prepared, responsive, and agile under these conditions is becoming a crucial success factor. Oracle Strategic Modeling can help you better navigate change to cope with uncertainty.
If your CFO’s questions regarding earnings, liquidity, and cash flow are unceasing and far-reaching, watch our on-demand webinar for a deep dive into strategic modeling. We modeled real-world scenarios to show how you can:
Quickly and easily develop a hierarchical model of your business
Leverage multiple pre-built functions to forecast key performance drivers
Provide transparency on forecasted financials via audit trail
Utilize goal seek to set financial targets and estimate the financials drivers necessary to achieve it
Perform sophisticated “what-if” analysis via simulations to improve the accuracy of your forecast
Use built-in dashboard functionality to deliver powerful reporting capabilities
While many stay-at-home orders have been lifted, consumers’ new digital buying behaviors and habits are here to stay. Watch our panel discussion on the accelerated need for commerce and learn how commerce and content can transform our digital economy.
Topics include:
-What is the “experience economy” and how do you leverage it? -If you move beyond product and price, what’s next?
-How business models have shifted and what you can do to break down silos and leverage new processes to capture the digital dollar.
-How organizations have built agile teams to address the ever-changing needs of customers, including responsive approaches that address the omnichannel consumer.
-Technologies that are best suited to enable your business and customers – and how headless commerce has changed the game.
-How the future of commerce is changing, and what you should do now to prepare.
Our panel features Jordan Jewell, IDC Research analyst known for his insight into the commerce industry. Joining him from Perficient is general manager Brian Beckham, who brings deep expertise in content management and empowering organizations in their digital transformations. Rounding out the panel is Episerver’s Joey Moore, who has spent the last decade helping organizations across the globe advance their digital maturity.
Centene's Financial Transformation Journey: A OneStream Success StoryPerficient, Inc.
Centene, a large multi-line managed care organization, was looking to modernize and streamline its corporate performance management (CPM) applications.
Centene had to move data between platforms multiple times during the close process so that close data could be fully consolidated and made available for reporting. This process had numerous challenges and inefficiencies that Centene wished to improve upon so that they could provide a more streamlined and more transparent process to the functional teams that leverage consolidated financials in their systems for reporting and analysis.
Centene chose OneStream XF for global and US consolidations, currency conversion, eliminations, and ownership percentage.
Michael Vannoni, director, financial systems solutions discussed the migration to OneStream XF including:
-Factors leading to the selection of OneStream XF
-Details of the solution design
-Benefits realized with global consolidation implementation
-Future planned enhancements
Preparing for Your Oracle, Medidata, and Veeva CTMS Migration ProjectPerficient, Inc.
There are multiple reasons why companies migrate to a new clinical trial management system (CTMS). Still, the two most common are mergers and acquisitions (i.e., CTMS consolidation) and the desire to switch CTMS vendors. Regardless of the reason, many of the best practices, processes, and tools are the same.
In this webinar, we looked at the migration approaches taken across several case studies. You’ll come away with an understanding of:
Pros and cons of each CTMS migration method
Types of migration tools, including APIs, ETL tools, and adapters
Approximate timelines and costs associated with each migration method
The topics discussed in this webinar can be applied to any CTMS migration project, whether you’re moving to or from Oracle’s Siebel CTMS, Medidata’s Rave CTMS, and Veeva’s Vault CTMS.
Accelerating Partner Management: How Manufacturers Can Navigate Covid-19Perficient, Inc.
The pandemic has ushered in a new normal for manufacturers, and the impact of digital communication is more important than ever.
View our on-demand webinar with Tony Kratovil, Regional Vice President of Manufacturing at Salesforce, and Eric Dukart, National Sales Executive at Perficient. They covered why the right digital strategies are critical for manufacturers in the wake of COVID-19.
Our webinar covered:
Current challenges with forecasting, collaboration, and disruptions to distribution networks.
Insights for stabilizing operations, accelerating partner management, and developing a digital strategy that differentiates your business.
Candid Q&A with real-world examples.
New Work.com resources to help manufacturers restart safely and rebuild.
Tools and resources to move forward – fast.
The Critical Role of Audience Intelligence with Eric Enge and Rand FishkinPerficient, Inc.
Things move quickly in marketing. How do you identify what your customers need and how you can help? Now more than ever, audience intelligence is the key.
Audience intelligence is about understanding your target customers, their needs, what resonates with them, and how you can reach them. Eric Enge (Digital Marketing Principal, Perficient) and Rand Fishkin (Co-Founder & CEO, SparkToro) discussed this topic live on May 7, 2020. Watch to hear tactics for gaining a better understanding of your customers, how to use audience intelligence to optimize your marketing now, and more.
Cardtronics, the global leader in ATM deployment and management, decided to retire its on-premises Hyperion solution to gain the operational efficiencies, features, and functionality provided by a best-in-class cloud solution.
Cardtronics chose Oracle EPM Cloud including Financial Consolidation and Close, Planning, Management Reporting, Account Reconciliation, Enterprise Data Management, as well as Oracle Analytics Cloud.
In this video, project owner Richard Ng, director, financial systems, Cardtronics, discusses the migration to Oracle EPM Cloud including:
Multi-release 18-month deployment schedule across multiple countries
Benefits of a global Chart of Accounts for ERP and EPM
Seamless integration across ERP Cloud, HCM Cloud, and EPM Cloud
Preparing for Project Cortex and the Future of Knowledge ManagementPerficient, Inc.
Microsoft has turned traditional enterprise content management on its head with its recent announcement of Project Cortex.
Project Cortex uses advanced artificial intelligence to harness collective knowledge from across the enterprise and automatically organize it into shared topics like projects, products, processes, and customers. Using AI, Cortex creates a knowledge network based on relationships among topics, content, and people and delivers it in the apps you use every day – Office, Outlook, and Teams.
This webinar examined Project Cortex in more detail, including:
• What is Project Cortex?
• Why is Project Cortex different than other knowledge network projects previously introduced?
• How does incorporating AI and automation change the game?
• What is possible with Project Cortex?
• What can you do to prepare?
Utilizing Microsoft 365 Security for Remote Work Perficient, Inc.
With an increasingly mobile workforce, and the spread of shadow IT, the rapid rise of cybercrime - companies must find unique ways to effectively manage their sprawling SaaS portfolio.
Crisis Management & Remote Work w/ Microsoft 365Perficient, Inc.
During this webinar, Perficient's Microsoft experts discuss best practices for leveraging Microsoft Teams for remote work collaboration and crisis communication.
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...DanBrown980551
Do you want to learn how to model and simulate an electrical network from scratch in under an hour?
Then welcome to this PowSyBl workshop, hosted by Rte, the French Transmission System Operator (TSO)!
During the webinar, you will discover the PowSyBl ecosystem as well as handle and study an electrical network through an interactive Python notebook.
PowSyBl is an open source project hosted by LF Energy, which offers a comprehensive set of features for electrical grid modelling and simulation. Among other advanced features, PowSyBl provides:
- A fully editable and extendable library for grid component modelling;
- Visualization tools to display your network;
- Grid simulation tools, such as power flows, security analyses (with or without remedial actions) and sensitivity analyses;
The framework is mostly written in Java, with a Python binding so that Python developers can access PowSyBl functionalities as well.
What you will learn during the webinar:
- For beginners: discover PowSyBl's functionalities through a quick general presentation and the notebook, without needing any expert coding skills;
- For advanced developers: master the skills to efficiently apply PowSyBl functionalities to your real-world scenarios.
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...Ramesh Iyer
In today's fast-changing business world, Companies that adapt and embrace new ideas often need help to keep up with the competition. However, fostering a culture of innovation takes much work. It takes vision, leadership and willingness to take risks in the right proportion. Sachin Dev Duggal, co-founder of Builder.ai, has perfected the art of this balance, creating a company culture where creativity and growth are nurtured at each stage.
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Albert Hoitingh
In this session I delve into the encryption technology used in Microsoft 365 and Microsoft Purview. Including the concepts of Customer Key and Double Key Encryption.
State of ICS and IoT Cyber Threat Landscape Report 2024 previewPrayukth K V
The IoT and OT threat landscape report has been prepared by the Threat Research Team at Sectrio using data from Sectrio, cyber threat intelligence farming facilities spread across over 85 cities around the world. In addition, Sectrio also runs AI-based advanced threat and payload engagement facilities that serve as sinks to attract and engage sophisticated threat actors, and newer malware including new variants and latent threats that are at an earlier stage of development.
The latest edition of the OT/ICS and IoT security Threat Landscape Report 2024 also covers:
State of global ICS asset and network exposure
Sectoral targets and attacks as well as the cost of ransom
Global APT activity, AI usage, actor and tactic profiles, and implications
Rise in volumes of AI-powered cyberattacks
Major cyber events in 2024
Malware and malicious payload trends
Cyberattack types and targets
Vulnerability exploit attempts on CVEs
Attacks on counties – USA
Expansion of bot farms – how, where, and why
In-depth analysis of the cyber threat landscape across North America, South America, Europe, APAC, and the Middle East
Why are attacks on smart factories rising?
Cyber risk predictions
Axis of attacks – Europe
Systemic attacks in the Middle East
Download the full report from here:
https://sectrio.com/resources/ot-threat-landscape-reports/sectrio-releases-ot-ics-and-iot-security-threat-landscape-report-2024/
Essentials of Automations: Optimizing FME Workflows with ParametersSafe Software
Are you looking to streamline your workflows and boost your projects’ efficiency? Do you find yourself searching for ways to add flexibility and control over your FME workflows? If so, you’re in the right place.
Join us for an insightful dive into the world of FME parameters, a critical element in optimizing workflow efficiency. This webinar marks the beginning of our three-part “Essentials of Automation” series. This first webinar is designed to equip you with the knowledge and skills to utilize parameters effectively: enhancing the flexibility, maintainability, and user control of your FME projects.
Here’s what you’ll gain:
- Essentials of FME Parameters: Understand the pivotal role of parameters, including Reader/Writer, Transformer, User, and FME Flow categories. Discover how they are the key to unlocking automation and optimization within your workflows.
- Practical Applications in FME Form: Delve into key user parameter types including choice, connections, and file URLs. Allow users to control how a workflow runs, making your workflows more reusable. Learn to import values and deliver the best user experience for your workflows while enhancing accuracy.
- Optimization Strategies in FME Flow: Explore the creation and strategic deployment of parameters in FME Flow, including the use of deployment and geometry parameters, to maximize workflow efficiency.
- Pro Tips for Success: Gain insights on parameterizing connections and leveraging new features like Conditional Visibility for clarity and simplicity.
We’ll wrap up with a glimpse into future webinars, followed by a Q&A session to address your specific questions surrounding this topic.
Don’t miss this opportunity to elevate your FME expertise and drive your projects to new heights of efficiency.
Generating a custom Ruby SDK for your web service or Rails API using Smithyg2nightmarescribd
Have you ever wanted a Ruby client API to communicate with your web service? Smithy is a protocol-agnostic language for defining services and SDKs. Smithy Ruby is an implementation of Smithy that generates a Ruby SDK using a Smithy model. In this talk, we will explore Smithy and Smithy Ruby to learn how to generate custom feature-rich SDKs that can communicate with any web service, such as a Rails JSON API.
Elevating Tactical DDD Patterns Through Object CalisthenicsDorra BARTAGUIZ
After immersing yourself in the blue book and its red counterpart, attending DDD-focused conferences, and applying tactical patterns, you're left with a crucial question: How do I ensure my design is effective? Tactical patterns within Domain-Driven Design (DDD) serve as guiding principles for creating clear and manageable domain models. However, achieving success with these patterns requires additional guidance. Interestingly, we've observed that a set of constraints initially designed for training purposes remarkably aligns with effective pattern implementation, offering a more ‘mechanical’ approach. Let's explore together how Object Calisthenics can elevate the design of your tactical DDD patterns, offering concrete help for those venturing into DDD for the first time!
Neuro-symbolic is not enough, we need neuro-*semantic*Frank van Harmelen
Neuro-symbolic (NeSy) AI is on the rise. However, simply machine learning on just any symbolic structure is not sufficient to really harvest the gains of NeSy. These will only be gained when the symbolic structures have an actual semantics. I give an operational definition of semantics as “predictable inference”.
All of this illustrated with link prediction over knowledge graphs, but the argument is general.
JMeter webinar - integration with InfluxDB and GrafanaRTTS
Watch this recorded webinar about real-time monitoring of application performance. See how to integrate Apache JMeter, the open-source leader in performance testing, with InfluxDB, the open-source time-series database, and Grafana, the open-source analytics and visualization application.
In this webinar, we will review the benefits of leveraging InfluxDB and Grafana when executing load tests and demonstrate how these tools are used to visualize performance metrics.
Length: 30 minutes
Session Overview
-------------------------------------------
During this webinar, we will cover the following topics while demonstrating the integrations of JMeter, InfluxDB and Grafana:
- What out-of-the-box solutions are available for real-time monitoring JMeter tests?
- What are the benefits of integrating InfluxDB and Grafana into the load testing stack?
- Which features are provided by Grafana?
- Demonstration of InfluxDB and Grafana using a practice web application
To view the webinar recording, go to:
https://www.rttsweb.com/jmeter-integration-webinar
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Tobias Schneck
As AI technology is pushing into IT I was wondering myself, as an “infrastructure container kubernetes guy”, how get this fancy AI technology get managed from an infrastructure operational view? Is it possible to apply our lovely cloud native principals as well? What benefit’s both technologies could bring to each other?
Let me take this questions and provide you a short journey through existing deployment models and use cases for AI software. On practical examples, we discuss what cloud/on-premise strategy we may need for applying it to our own infrastructure to get it to work from an enterprise perspective. I want to give an overview about infrastructure requirements and technologies, what could be beneficial or limiting your AI use cases in an enterprise environment. An interactive Demo will give you some insides, what approaches I got already working for real.
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf91mobiles
91mobiles recently conducted a Smart TV Buyer Insights Survey in which we asked over 3,000 respondents about the TV they own, aspects they look at on a new TV, and their TV buying preferences.
The Art of the Pitch: WordPress Relationships and SalesLaura Byrne
Clients don’t know what they don’t know. What web solutions are right for them? How does WordPress come into the picture? How do you make sure you understand scope and timeline? What do you do if sometime changes?
All these questions and more will be explored as we talk about matching clients’ needs with what your agency offers without pulling teeth or pulling your hair out. Practical tips, and strategies for successful relationship building that leads to closing the deal.
2. 2
Tom Hogan
Chief OperatingOfficer
Who We Are
AN INTRODUCTION TO
We’re a global digital consultancy transforming how the
world's leading enterprises and biggest brands connect
with customers and grow their businesses.
With Perficient, you get experience and expertise,
speed and agility, and a healthy dose of pragmatism to
drive your business forward.
3. 3
~4,500
Colleagues
WE ARE
Global in Our Delivery
We have office locations across North America and fully owned
global and domestic delivery centers around the world.
Allentown, PA
Ann Arbor, MI
Atlanta, GA
Boston, MA
Bozeman, MT
Cedar Rapids, IA
Charlotte, NC
Chicago, IL
Columbus, OH
Dallas, TX
Denver, CO
Detroit, MI
Fairfax, VA
Fargo, ND
Houston, TX
Irvine, CA
Lafayette, LA
Milwaukee, WI
Minneapolis, MN
New York, NY
San Francisco, CA
Seattle, WA
St. Louis, MO
Toronto, ON
Washington, D.C.
North America
Latin America
Mexico City, Mexico
Medellin, Colombia
Bogota, Colombia
Cali, Colombia
Chennai, India
Nagpur, India
Bangalore, India
India
Hangzhou, China
China
Oxford, UK
Novi Sad, Serbia
Europe
4. 4
AT-A-GLANCE
Perficient Profile
Alliance partnerships
with major tech
vendors
Multiple vendor &
industry tech and
growth awards
Global delivery centers
in China, India and
Latin America
Dedicated
solution
practices
35
Global Locations
$565M
2019 Revenue
1997
Founded in
~4,500
Colleagues
~90%
Repeat Business Rate
PRFT
Public, NASDAQ
5. 5
Industry Expertise
Our experience in the life sciences industry empowers us to help companies
discover, develop, and manufacture products that help people feel better and live
longer. We also help them enhance their customer experience and achieve
operational excellence.
I NDUSTRY
Life Sciences 30+ of the world's leading
public pharmaceutical,
biotechnology, and medical device
companies count on us .
We helped a pharmaceutical giant
transform the way it performs its medical
coding activities.
Project Spotlight
DigitalTechnologyStrategy Clinical Safety
6. 6
Caroline Halsey
Director, Life Sciences
Caz.Halsey@Perficient.com
Damon Fahimi
Product Manager, Uppsala Monitoring Centre
Damon.Fahimi@who-umc.org
Today’s Speakers
7. 77
Agenda
• WHODrug Global and Drug Coding
• An Introduction to WHODrug Koda
• Why use Koda
• Methods of Using Koda
• Perficient Koda Interface - Prototype
• Use Cases
• How to Find Out More
8. 8
Uppsala Monitoring Centre & WHODrug Global
Productname Drugcode ActiveIngredient(s) ATC
ASPIRIN
[ACETYLSALICYLIC
ACID]
00002701004 Acetylsalicylic acid A01AD, Other agents for local oral treatment
B01AC,Platelet aggregation inhibitors excl. heparin
M02AC,Preparations with salicylic acid derivatives
N02BA, Salicylic acid and derivatives
WHODrugGlobal
9. 9
The Challenges of Structuring Drug Data
Staffing
Drug coding
requires highly
skilled, educated
and trained staff
IncreasingVolumes
Both long-term and
short-term
demands
Quality&
Consistency
Dynamic nature of
drug coding. How
to keep consistency
in coding teams?
Tools & Processes
Dependencies on
tools & synonym
lists not delivering
optimal support for
drug coding
10. 10
What if…
...drug coding staff could spend their time only on the most relevant cases?
…a more significant part of the drug coding could be automated, thereby helping cope with both
short- and long-term peaks?
…UMC could gather know-how from the industry and, with the help of technology,
increase drug coding consistency?
…there was a plug-in to current processes and tools, enhancing drug coding?
Project goal:
Find an intelligent approach to automating drug coding using machines
and efficiently using the human brain when needed
11. 11
The Result: WHODrug Koda – Born in 2019
Verbatim
+
Route*
+
Indication*
* If available
Drug Name
Coding
ATC Selection
13. 13
Machine Learning Applied
How? For What? TrainingData?
Supervised machine
learning via logistical
regression
Primarily ATC code
selection, but also drug
name coding
Millions of data points
from VigiBase
Trainingdata
Input A → Output A
Input B → Output A
Input C → Output B
Prediction
Non-trainingdata
Input D → Output A
More than 500,000
“classes” of drug names
Around 1400 “classes” of ATC
codes
14. 14
VigiBase: An Invaluable Asset for Training
• Training data is key!
• VigiBase used to train and update WHODrug Koda
+ millions of additional data points
Coded in WHODrug Global
Drug name ATC code and text
Acetazolamide
S01EC, Carbonic anhydrase
inhibitors
Acetazolamide
S01EC, Carbonic anhydrase
inhibitors
Acetazolamide C03, Diuretics
Acetazolamide N03AX, Other antiepileptics
Unprocessed Data
Verbatim Route Indication
Acetasolamide Oral Cataract surgery
Acetazolamide
tablet 250mg
Unknown Retinitis central
Acetazolamide Oral Secondary hypertension
Acetazolamide Oral Seizure
15. 15
“Only” Machine Learning – Not Enough
Built-in CodingRules Spell Checks and Algorithms Know-how and Controlled
Feedback Loops
Following the latest
regulatory expectations
and best practices for
WHODrug coding
Making sense of the data
Systemic
(foundational)
Dynamic
(supplementary)
Examples of drug verbatims
Naphazoline (naphcon) 0.1% ophthalmic solution
sodium fluoride (prevident5000 booster plus) 1.1% dental
paste
ERELSA TABLETS 50MG
Pharmacists and medical
expertise at UMC and
feedback from users
16. 16
Average Results With External Data
Drugname coding ATC Selection
≈ 95%of all drug namescoded*
*High certainty: 80%; Lower certainty: 15%; Uncoded: 5%
≈ 100% selected**
**High certainty: 80%; Lower certainty: 20%
What about the precision for the predictions?
≈ 99%***
***Based on high certainty predictions
For an example;please see: Herrgårdet al., 2020. Assessment of Machine Learning Methods in Coding of Concomitant Medications in Clinical Trials.Abstract for the 2020
PhUSE Connect USA 2020. https://www.phusewiki.org/docs/2020%20US%20Connect%20Florida/Presentations/ML/Final%20Papers/ML13%20pdf.pdf
17. 17
How to Access WHODrug Koda
WEB APPLICATION
For evaluations / smaller studies
API
Allowing implementation within
current processes
18. 18
UMC and Perficient
• Perficient is licensed and approved by UMC for integrating WHODrug Koda
into medical coding tools
• Contact UMC for general questions about WHODrug Koda
• Contact Perficient for questions about our services
https://www.who-umc.org/whodrug/whodrug-portfolio/whodrug-koda/
19. 19
Why Use Koda
Koda can support medical coding in various scenarios:
• Assigning drug codes only
• Assigning drug codes and preferred ATC codes based on indication
• Recoding / refreshing WHODrug encoded data
• Up-versioning to a more recent version
• Up-versioning from B2 to B3 format
Koda is already trained
• Time, effort, and volume of data required to train an AI system is significant
• Koda is already trained and ready to use
20. 20
Methods of Using Koda
Two ways to use Koda:
1. Upload / download data through Koda UI on UMC website
• Requires manual process of data extraction and bringing coding results back
into source data
• Koda UI is currently used by UMC customers
2. Upload / download data through UMC Koda webservice API
• Allows direct integration of Koda functionality into coding process
• Requires technical knowledge of webservice integration into systems
21. 21
Perficient Koda Interface – Prototype
Perficient has built a prototype of a generic Oracle interface to the Koda
webservice API
• Consists of a table for drug data to be coded and some programming
objects
• Oracle-based
• Requirements:
• Oracle 11 or above
• UMC security certificates installed
• Open network connection from DB server to UMC server
• Additional custom adapter required for each specific source system
(medical coding system, PV system, etc.)
22. 22
WHODrug Koda
Interface
Source System
YOUR COMPANY
WHODrug Koda
Encoded drug or
suggested drug
Drugs to be coded
CustomAdapter
Drugs to be coded
Encoded drug or
suggested drug
23. 23
Example Workflow Step 1 – Table With Uncoded Data
Line Drug Route Indication Code ATC Comments
1 Paracetamol Entry with single ATC code
2 Aspirin Oral Anti-coagulant Entry with 4 ATC codes from 4 different classes
3 Aspirin Thrombosis Entry with 4 ATC codes from 4 different classes
4 Aspirin thrombose Entry with 4 ATC codes from 4 different classes
5 Aspirin Thrombosis prophylaxis Entry with 4 ATC codes from 4 different classes
6 Aspirin Headache in the morning Entry with 4 ATC codes from 4 different classes
7 Artificial tears Drops Non-unique entry including an umbrella term
8 A b c Another entry ABC exists
9 ibuprofen headache Entry with some ATCs not very distinctive (e.g. two from M
class)
10 Vitamins Non-unique drug name (one regular entry and one umbrella
term)
11 x37ytc12 Non-existing entry
12 sebcur Unique name which was non-unique in older versions
13 sebcur [salicylic acid] Non-unique entry as in older version
14 sebcur salicylic acid Concatenation of name with ingredients
24. 24
Example Workflow Step 2 - Interface Execution
1. Transformationof datato be coded intoKodaformat (JSON)
{"WhoDrugVersionShortName":"GLOBALB3Sep19","UsePreferredBaseRule":"true","UseGenericRule":"true","Description":"ClientJob ID =
13774594","DrugsToCode":[{"Id":13774573,"Verbatim":"paracetamol","Route":null,"Indication":"headache"},{"Id":13774574,"Verbatim":"aspirin","Route":"oral","Indication":"anti-
coagulant"},{"Id":13774575,"Verbatim":"aspirin","Route":null,"Indication":"thrombose"},{"Id":13774576,"Verbatim":"aspirin","Route":null,"Indication":"thrombosis"},{"Id":13774577,"Ver
batim":"aspirin","Route":"oral","Indication":"thrombosis prophylaxis"},{"Id":13774578,"Verbatim":"aspirin","Route":null,"Indication":"headachein the morning"},{"Id":13774579,
"Verbatim":"acetylsalycilicacyd","Route":null,"Indication":null},{"Id":13774580,"Verbatim":"aspirin50mg","Route":null,"Indication":null},{"Id":13774581,"Verbatim":"ab c","Route":null,
"Indication":null},{"Id":13774582,"Verbatim":"artificaltears","Route":"drops","Indication":null},…
2. CreateHTTPSconnection to Kodawebservice API using UMCsecurity certificates,
senddata, andget a response
{"Id":"db7a0032-3656-4736-864e-d0d75495d8b6","Description":"ClientJob ID = 13774594","WhoDrugVersionLongName":"WHODRUGGLOBAL B3 September 1,
2019","WhoDrugVersionShortName":"GLOBALB3Sep19","UsePreferredBaseRule":true,"UseGenericRule":true,"EncodingJobStatus":"Finished","QueuedDateUTC":"2020-01-
31T16:29:56.1800000Z","StartedDateUTC":"2020-01-31T16:29:56.6400000Z","FinishedDateUTC":"2020-01-31T16:30:02.3500000Z","NoOfRecords":21,"CodingItem“
:[{"Id":"13774573","Verbatim":"paracetamol","Route":null,"Indication":"headache","EncodedDrug":{"Tradename":"PARACETAMOL","Ingredients":["Paracetamol"],"DrugCode":"000200
01001","AtcCode":"N02BE","SuggestedAtcs":[]},"SuggestedDrugs":[],"CodingPath":"DirectHit"},{"Id":"13774574","Verbatim":"aspirin","Route":"oral","Indication":"anti-
coagulant","EncodedDrug":{"Tradename":"ASPIRIN[ACETYLSALICYLICACID]","Ingredients":["Acetylsalicylicacid"],"DrugCode":"00002701004","AtcCode":"B01AC",
"SuggestedAtcs":[]},"SuggestedDrugs":[],"CodingPath":"NonUniqueByIndication"},{"Id":"13774575","Verbatim":"aspirin","Route":null,"Indication":"thrombose","EncodedDrug":{"Tradena
me":"ASPIRIN[ACETYLSALICYLICACID]","Ingredients":["Acetylsalicylicacid"],"DrugCode":"00002701004","AtcCode":"N02BA","SuggestedAtcs":[]},"SuggestedDrugs":[]…
3. Parseresponse fromKodaformat(JSON) and updatedatatable
25. 25
Example Workflow Step 3 – Table Contains Coded Data
Line Drug Route Indication Code ATC Comments
1 Paracetamol 00020001001 N02BE ATC provided as drug has only one ATC code
2 Aspirin Oral Anti-coagulant 00002701004 B01AC ATC code correct
3 Aspirin Thrombosis 00002701004 B01AC ATC code correct
4 Aspirin thrombose 00002701004 N02BA Wrong ATC (indication misspelled)
5 Aspirin Thrombosis
prophylaxis
00002701004 B01AC ATC code correct
6 Aspirin Headache in the
morning
00002701004 N02BA ATC code correct
7 Artificial tears Drops No code as non-unique,but list of suggested drugs as
expected
8 A b c 00256502021 No ATC code as no indication
9 ibuprofen headache 00109201001 No ATC code, but 2 suggested ATC codes from M class
10 Vitamins No code as non-unique.Returns 2 suggested drugs as
expected, one of which is an umbrella term
11 x37ytc12 Uncoded as expected
12 sebcur 00021201106 No ATC code as no indication
13 sebcur [salicylic acid] 00021201106 Entry from old WHODrug version correctly coded
although no longer non-unique in new version
14 sebcur salicylic acid No encoded drug code, but single suggested drug code,
which is correct
26. 26
Potential Interface Use
Possible integrations of an Oracle-based interface could include:
• Argus Safety
• Connect Koda as WHODrug interactive coding webservice to Argus Product screen
• Integrate WHODrug coding via Koda into custom case save procedure
• Oracle TMS
• Auto-create unapproved VTAs for coding omissions which have been sent to Koda
We are prototyping an Oracle-based approach. The integration of Koda with other source systems can be
explored.
28. 28
Caroline Halsey
Director, Life Sciences
Caz.Halsey@Perficient.com
Damon Fahimi
Product Manager, Uppsala Monitoring Centre
Damon.Fahimi@who-umc.org
Thank You
Editor's Notes
My name is Caroline Halsey, I am a Director in the Life Sciences Business Unit at Perficient. I have 20 years experience in the pharmaceutical industry including:
Clinical data management
Project & program management
Process design & system implementation
Computer system validation
For the past few years I have been focussed on medical coding processes and systems. Today I am here to describe about how you could integrate the UMC’s WHODrug Koda coding engine into your coding process via its webservice API and I am pleased to be joined by Damon Fahimi from the UMC to discuss this.
Damon will introduce WHODrug coding and WHODrug Koda, then I will discuss how it could be used and what we are working on at Perficient to enable integration of Koda into medical coding processes
As you have heard, Koda can help you with your daily drug coding business, but it can also help to recode data by upgrading your WHODrug version or even your WHODrug format.
For example, when recoding a study from B2 to B3 a large number of terms may no longer code. Submitting those terms to WHODrug Koda could dramatically reduce the manual effort of recoding.
One of the main challenges in the use of AI in medical coding is the time, effort and volume of data required to train the AI system. With WHODrug KODA the training has already been done for you."
We’ve heard from Damon, one way to use Koda is via uploading and downloading data through the Koda UI, but it is also possible to fully integrate it into your systems by using the Koda webservice Application Programming Interface.
Now, using webservice APIs is not always straightforward, as you have to deal with technicalities like transforming data, generating network traffic, security cerificates etc.
It would simplify integration if you had an additional interface level available, which hides all the technical bits. Some of my Perficient colleagues have built a prototype of such an interface, and this is what I’d like to talk about today.
I’ll give an overview of the design, usage and possible integration and let you know how to find out more if you are interested
In order to build such an interface we needed first to decide on a platform, and we have chosen Oracle. This choice was kind of arbitrary, and of course you could build a similar interface on any other platform.
This prototype consists basically of
a table which contains the drug data to be coded and mimics the source application
plus some programming objects in PL/SQL, which interact with the webservice API right out of the database.
The only system requirement is that you have Oracle version 12 or higher, and you need to have the UMC certificates installed and an open network connection from your database to the UMC server. No further infrastructure is needed.
Here you can see the designed workflow.
The source system or application sends the drugs to be coded via the custom adapter to the interface.
The interface converts the data into the format expected by the Koda application and calls the Koda webservice API
It then gets back the response from Koda with coding information, parses the response and updates the drug data with the coding information in the source system.
Triggering the interface could of course be an automated process, e.g. a regular batchjob or automated execution if the table of drugs has been updated.
This design actually hides all the technical complicated bits from the end user or end application.
Now lets have a look at a real example.
The columns with blue heading here reflect data which is exchanged with Koda.
Initially the drug table contains drug verbatims, some of them with route and / or indication.
Now we trigger the interface.
The interface now
Transforms the data into Koda format
Builds the network connection and send data to Koda
Gets the response in Koda format
Parses the response
Puts coding information back into the source table
This is the part that nobody wants to deal with as it looks like this <trigger animation>
This is what the table looks like after the interface execution.
The interface has updated the code and ATC code column with some values.
Please note that here you can only see the encoded information, the comments column shows some information on suggested drugs if available. Lets have a look at a few examples in more detail...
Line 1 is paracetamol, which is correctly coded to its drug code and ATC code although no indication was provided. This is because Paracetamol has only one ATC code.
Lines 2 to 6 are some records with Aspirin, which has 4 ATC codes from 4 different classes, so is fairly distinctive. For correctly spelled indications the drug code and ATC is always correct, for the misspelled indication in line 4 the ATC code is incorrect.
Line 7 to 11 are some examples where we have tried non-unique drugs, non-existing names, umbrella terms, drugs with multiple ATC codes from the same class etc. All codes which were provided were as expected and correct. Suggested information is also as expected and correct.
Of special interest are lines 12 to 14, which is an example on how you could use Koda for a version or format upgrade. The tradename SEBCUR was non-unique in a previous WHODrug version and became unique in a more recent version. Koda is able to correctly encode or suggest the code from the current version if you pass in the tradename with ingredients attached as it was stored in the previous version.
Such an Oracle based interface could be potentially integrated with any Oracle based system, for example Argus Safety, where you could use it for coding during case entry, or for coding during case save.
Or you could integrate it with Oracle TMS, where you could for example auto-create non-approved VTAs for coding omissions which you send to Koda and where Koda returns a code.
As already mentioned, this prototype is currently Oracle based, but could be explored for other platforms as well, so please don’t go away with the iompression that this would only work if you use Argus and TMS.
Seed Question: Will this interface only work for Oracle-based systems?
Response: the prototype interface is Oracle based, but with the appropriate custom adapter, in principle, any source system could be used.